Valion Bio (VBIO) Intangibles (2025 - 2026)

Valion Bio (VBIO) posted quarterly Intangibles of $2.2 million for Q4 2025, little changed quarter-over-quarter from $2.2 million in Q3 2025.

Valion Bio (VBIO) Intangibles (2025 - 2026) Analysis & Trends

Valion Bio's Intangibles history runs 1 years deep, the most recent figure standing at $2.2 million for Q4 2025.

In Q4 2025, Intangibles changed N/A year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (changed N/A YoY), while the FY2025 annual figure was $2.2 million, changed N/A from the prior year.
Intangibles for Q4 2025 stood at $2.2 million, roughly flat from $2.2 million in the prior quarter.
The five-year high for Intangibles was $2.2 million in Q3 2025, with the low at $2.2 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Vertex Pharmaceuticals	139.57 Bn	131.72 Bn	2.84 Bn	412.80 Mn
2	Regeneron Pharmaceuticals	86.71 Bn	78.72 Bn	3.93 Bn	1.31 Bn
3	Argenx Se	65.44 Bn	60.25 Bn	1.37 Bn	266.00 Mn
4	Moderna	60.06 Bn	54.93 Bn	52.00 Mn	-
5	BeOne Medicines	42.16 Bn	37.06 Bn	1.53 Bn	60.96 Mn
6	Alnylam Pharmaceuticals	31.89 Bn	28.58 Bn	992.69 Mn	-
7	BioNTech SE	28.11 Bn	9.72 Bn	668.28 Mn	-
8	Insmed	27.59 Bn	26.43 Bn	358.27 Mn	93.49 Mn
9	Royalty Pharma	27.33 Bn	26.49 Bn	-	-
10	Valion Bio	407,627.64	-1.79 Mn	-45,000.00	2.24 Mn

Download Data